News

Beta-Catenin: An Elusive Target - New Chemistry as a Skeleton Key for Oncological Drugs

Captor reports MCL-1 Degraders: What Makes Them a Game-Changer? A New Era in the Fight Against Cancer

Captor Therapeutics in Communications Chemistry  

New Hope in Liver Cancer Treatment – a Clinical Trial of the Innovative Drug CT-01 Has Been Initiated

Captor Therapeutics wins prestigious EIC Accelerator recommendation for funding of project CT-03

Captor Therapeutics Announces Clinical Candidate for Project CT-03!

Captor Therapeutics has applied for approval to conduct a Phase 1 clinical trial in Patients with Hepatocellular Carcinoma

Captor Therapeutics has signed an agreement for the implementation and funding of Stage II of the CT-01 Project